Treatment and education reduce the severity of schistosomiasis periportal fibrosis

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 46, Issue 4, 2013, Pages 472-477

  Silva, Paula Carolina Valença ^a   Leal, Tallita Veríssimo ^a   Domingues, Ana Lúcia Coutinho ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Federal University of Pernambuco   (Brazil)

Author keywords

Epidemiology; Periportal fibrosis; Schistosomiasis mansoni

Indexed keywords

OXAMNIQUINE; PRAZIQUANTEL;

ADULT; AGED; ALCOHOLISM; ARTICLE; BRAZIL; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ECHOGRAPHY; EDUCATIONAL STATUS; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SCHISTOSOMIASIS MANSONI; WATER CONTAMINATION; ADOLESCENT; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; LIVER CIRRHOSIS; PARASITOLOGY; PORTAL VEIN; SEVERITY OF ILLNESS INDEX; SPLENIC DISEASES; ULTRASTRUCTURE; VERY ELDERLY; YOUNG ADULT;

SCHISTOSOMA MANSONI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAZIL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PORTAL VEIN; SCHISTOSOMIASIS MANSONI; SEVERITY OF ILLNESS INDEX; SPLENIC DISEASES; YOUNG ADULT;

EID: 84882999822     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0110-2013     Document Type: Article

References (23)

1. World Health Organization (WHO). Programs and projects: schistosomiaisis. A major public health. 2010. [Cited 2010 February 25]. Available at: http:// www.who.int/schistosomiaisis/en/.
2. Amaral RS, Tauil PL, Lima DD, Engels D. An analysis of the impact of the schistosomiasis control programme in Brazil. Mem Inst Oswaldo Cruz 2006; 101:79-85.
3. Katz N, Peixoto SV. Análise crítica da estimativa do número de portadores de esquistossomose mansoni no Brasil. Rev Soc Bras Med Trop 2000; 33:303-308.
4. Prata A, Ruiz-Guevara R, Antunes CMF, Marinho CC, Queiroz LC, Voieta I, et al. Comparação entre achados clínicos e ultrassonográficos no diagnóstico da fibrose periportal em uma área endêmica de esquistossomose no Brasil. Rev Soc Bras Med Trop 2010; 43:129-134.
5. Abath FGC, Morais CNL, Montenegro CEL, Wynn TA, Montenegro SML. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 2006; 22:85-91.
6. Andrade ZA. Schistosomiasis and liver fibrosis. Parasite Immunology 2009, 31:656-663.
7. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNFalpha with aggravation of disease. J Immunol 2002; 169:929-936.
8. Domingues AL, Lima AR, Dias HS, Leão GC, Coutinho A. Na ultrasonographic study of liver fibrosis in patients infected with Schistosoma mansoni in northeast Brazil. Trans R Soc Trop Med Hyg 1993; 87:555-558.
9. Araujo KCGM, Resendes APC, Souza-Santos R, Silveira Júnior JC, Barbosa CS. Análise espacial dos focos de Biomphalaria glabrata e de casos humanos de esquistossomose mansônica em Porto de Galinhas, Pernambuco, Brasil, no ano 2000. Cad Saude Publica 2007; 23:409-417.
10. Pordeus LC, Aguiar LR, Quinino LRM, Barbosa CS. A ocorrência das formas aguda e crônica da esquistossomose mansônica no Brasil no período de 1997 a 2006: uma revisão de literatura. Epidemiol Serv Saude 2008,17:163-175.
11. Dessein A, Chevillard C, Arnaud V, Hou X, Hamdoun AA, Dessein H, et al. Variants of CTGF are associated with hepatic fibrosis in chinese, sudanese, and brazilians infected with schistosomes. J Exp Med 2009; 12:1-8.
12. Brandt CT, Rino M, Pitta MGR, Muniz JS, Silveira DO, Castro CMMB. Avaliação das citocinas Il-10 e Il-13 como mediadores na progressão da fibrose de symmers em portadores de esquistossomose mansônica na forma hepatoesplênica. Rev Col Bras Cir 2010; 37:333-337.
13. Joshi VA, Roberts AE, Kucherlapati R. Towards a Treatment for RASMAPK pathway disorders. In: Zenker M, editor. Syndrome and related disorders: A matter of deregulated ras signaling. Monographs in human genetics: Basel Karger; 2008. p. 151-164.
14. Richter J, Domingues AL, Barata CH, Prata AR, Lambertucci JR. Report of the second satellite symposium on ultrasound in schistosomiasis. Mem Inst Oswaldo Cruz 2001; 96:151-156.
15. Domingues ALC. Diagnóstico por imagem. In: Carvalho OS, Coelho PMZ, Lenzi HL, editors. Schistosoma mansoni e esquistossomose:uma visão multidisciplinar. Rio de Janeiro: Editora Fiocruz; 2008. p.929-61.
16. Coutinho A, Domingues ALC. Specific Treatment of advanced schistosomiasis liver disease in man: favourable results. Mem Inst Oswaldo Cruz 1987; 82:335-340.
17. Voieta I, Queiroz LC, Andrade LM, Silva LCS, Fontes VF, Barbosa AJ, et al. Imaging techniques and histology in the evaluation of lver fibrosis in hepatoesplenic schistosomiasis mansoni in Brazil: a comparative study. Mem Inst Oswaldo Cruz 2010; 105:414-421.
18. Espirito Santo MCC, Azeredo LM, Teles HMS, Gryschek RCB, Ferreira CS, Amato Neto V. Abdominal ultrasound in the evaluation of fibrosis and portal hypertension in area of schistosomiasis low endemicity. Rev Inst Med Trop Sao Paulo 2008; 50:117-119.
19. Silva PCV, Domingues ALC. Aspectos epidemiológicos da esquistossomose hepatoesplênica no estado de Pernambuco, Brasil. Epidemiol Serv Saude 2011; 20:327-336.
20. Barbosa CS, Barbosa FS. Padrão epidemiológico da esquistossomose em comunidade de pequenos produtores rurais de Pernambuco, Brasil. Cad Saude Publica 1998; 14:129-137.
21. Resendes APC, Souza SR, Barbosa CS. Hospitalization and mortality from mansoni schistosomiasis in the state of Pernambuco, Brazil, 1992/2000. Cad Saude Publica 2005; 21:1392-1401.
22. Barbosa CS, Araújo KC, Sevilla MAA, Melo F, Gomes ECS, Santos RS. Current epidemiological status of schistosomiasis in the state of Pernambuco, Brazil. Mem Inst Oswaldo Cruz 2010; 105:549-554.
23. Prata AR, Bina JC. Development of the hepatoesplenic form schistosomias. Gaz Med Bahia 1968; 68:49-60.